Mads Hald Andersen 

Clinical Professor and Chief Physician Center for Cancer Immune Therapy, Herlev and Gentofte Hospital

Email: mads.hald.andersen@regionh.dk

Mads Hald Andersen, MD, PhD, Dr.Techn., is a Clinical Professor at the University of Copenhagen and Director and Co-Founder of the Center for Cancer Immune Therapy (CCIT-DK) at Herlev and Gentofte Hospital. He holds doctoral degrees from both the University of Copenhagen and the Technical University of Denmark (DTU).

His research focuses on cancer immunotherapy, and he has pioneered Immune Modulatory Vaccines (IMVs) targeting the tumor microenvironment (TME). He identified anti-regulatory T cells (anti-Tregs) that selectively target immune-suppressive factors within the TME.

With more than 235 scientific publications and over 20 patents, he has significantly advanced the field, leading ongoing clinical trials in Europe and the U.S.

As a leading figure in translational research, Mads Hald Andersen combines academic excellence with entrepreneurial innovation. He has co-founded several biotechnology companies, including Survac and the Nasdaq-listed IO Biotech, with the goal of translating scientific discoveries into new treatment options for patients with cancer.

 

Herlev and Gentofte Hospital

Herlev and Gentofte Hospital is a leading research institution where specialised research is deeply integrated with clinical practice across all departments.

The hospital is internationally recognised for advanced research in cardiopulmonary diseases, focusing on heart failure, arrhythmias, and pulmonary conditions, as well as in oncology, with innovative studies in cancer diagnostics, immunotherapy, and personalized treatment strategies. Dermatology and allergology research are also prominent, addressing chronic skin conditions, autoimmune diseases, and allergy mechanisms.

The hospital’s strong academic environment is supported by extensive collaborations with national and international universities, local authorities, and pharmaceutical companies, fostering continuous innovation and improvements in patient care.

 

 

See publications here